AMAIA SORALUCE OLAÑETA-rekin lankidetzan egindako argitalpenak (7)
2020
-
Impact of augmented renal clearance on the pharmacokinetics of linezolid: Advantages of continuous infusion from a pharmacokinetic/pharmacodynamic perspective
International Journal of Infectious Diseases, Vol. 93, pp. 329-338
-
Novel population pharmacokinetic model for linezolid in critically ill patients and evaluation of the adequacy of the current dosing recommendation
Pharmaceutics, Vol. 12, Núm. 1
2019
-
Pharmacokinetics of linezolid in critically ill patients on continuous renal replacement therapy: Influence of residual renal function on PK/PD target attainment
Journal of Critical Care, Vol. 50, pp. 69-76
2018
-
Analisi farmakozinetiko/farmakodinamikoa antimikrobianoen erabilera hobetzeko gaixo larrietan
Ekaia: Euskal Herriko Unibertsitateko zientzi eta teknologi aldizkaria, Núm. 33, pp. 19-33
-
Population pharmacokinetics of daptomycin in critically ill patients
International Journal of Antimicrobial Agents, Vol. 52, Núm. 2, pp. 158-165
2015
-
Population pharmacokinetic models for cefuroxime and metronidazole used in combination as prophylactic agents in colorectal surgery: Model-based evaluation of standard dosing regimens
International Journal of Antimicrobial Agents, Vol. 45, Núm. 5, pp. 504-511
2014
-
Population pharmacokinetics of piperacillin and tazobactam in critically ill patients undergoing continuous renal replacement therapy: Application to pharmacokinetic/pharmacodynamic analysis
Journal of Antimicrobial Chemotherapy, Vol. 69, Núm. 1, pp. 180-189